{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:58:58Z","timestamp":1791583138029,"version":"4.3.4"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Early-onset MS (EOMS) and late-onset MS (LOMS) differ in terms of symptom presentation, disease progression, and disability outcomes. This study aims to evaluate the clinical characteristics of patients with EOMS and LOMS in Lithuania. Materials and Methods: A retrospective analysis of patients\u2019 medical records was conducted at the Lithuanian University of Health Sciences, Kaunas Clinics Department of Neurology. This study included 97 patients with multiple sclerosis, of which 34 were diagnosed with EOMS and 63 with LOMS. Results: The female\/male ratio did not differ significantly in the EOMS group (1.26:1), while in the LOMS group, the female-to-male ratio was 2:1. All EOMS patients were diagnosed with relapsing\u2013remitting multiple sclerosis (RRMS), while in the LOMS group, RRMS was observed in 55.6%, secondary progressive multiple sclerosis (SPMS) was observed in 27%, and primary progressive multiple sclerosis (PPMS) was observed in 17.4% of patients (p &lt; 0.001). The most common initial symptoms in the EOMS group were brainstem dysfunction (50%), and sensory (38.2%) and visual (26.5%) disorders, whereas LOMS patients predominantly experienced brainstem dysfunction (50.8%) and motor impairments (47.6%). The EOMS group experienced more clinical relapses in the first year after diagnosis, along with more frequent radiological signs of disease activity compared to LOMS (p &lt; 0.001). Both groups demonstrated a significant increase in Expanded Disability Status Scale (EDSS) score at the last follow-up visit compared to the baseline, while the LOMS group had higher EDSS scores both at the baseline and at the last follow-up compared to the EOMS group (p &lt; 0.001). Only LOMS patients had an increase in Multiple Sclerosis Severity Score (MSSS) at the last follow-up compared to the baseline (p = 0.028), and MSSS was higher than in EOMS patients both at the baseline (p = 0.004) and the last follow-up (p &lt; 0.001). Conclusions: There was no significant gender difference in the EOMS group, whereas in the LOMS group, females were predominant. Both groups had RRMS as the most common disease course. At the onset of MS, brainstem dysfunction was the most common symptom in both patient groups. EOMS patients had a more active disease course, in contrast to LOMS patients, who exhibited higher levels of disability, suggesting a progressive disease.<\/jats:p>","DOI":"10.3390\/medicina61010107","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T04:01:52Z","timestamp":1736740912000},"page":"107","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Characteristics of Early-Onset and Late-Onset Multiple Sclerosis in Patients from Lithuania"],"prefix":"10.3390","volume":"61","author":[{"given":"Emilija","family":"\u0160laj\u016bt\u0117","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Lithuanian University of Health Science, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglis","family":"Vi\u010dka\u010dka","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Lithuanian University of Health Science, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0310-9553","authenticated-orcid":false,"given":"Tautvydas","family":"Kl\u0117g\u0117ris","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Faculty of Medicine, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-4574","authenticated-orcid":false,"given":"Ingrida","family":"Ulozien\u0117","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Faculty of Medicine, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8772-6810","authenticated-orcid":false,"given":"Renata","family":"Balnyt\u0117","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2022","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e200025","DOI":"10.1212\/NXI.0000000000200025","article-title":"Toward Precision Phenotyping of Multiple Sclerosis","volume":"9","author":"Pitt","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101497","DOI":"10.1016\/j.disamonth.2022.101497","article-title":"Pathogenesis and management of multiple sclerosis revisited","volume":"69","author":"Shah","year":"2023","journal-title":"Disease-a-Month"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40893-017-0022-6","article-title":"Pediatric versus adult MS: Similar or different?","volume":"2","author":"Ghezzi","year":"2017","journal-title":"Mult. Scler. Demyelinating Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/0004-282x20170070","article-title":"Late onset multiple sclerosis: Concerns in aging patients","volume":"75","author":"Lotti","year":"2017","journal-title":"Arq. Neuro-Psiquiatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/jnnp-2022-329049","article-title":"Shift of multiple sclerosis onset towards older age","volume":"93","author":"Prosperini","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Brola, W., Steinborn, B., \u017bak, M., Mazurkiewicz-Be\u0142dzi\u0144ska, M., J\u00f3\u017awiak, S., Sobolewski, P., Wilski, M., Bilska, M., Siedlarska, M., and Puzio-Bochen, I. (2022). The Clinical and Epidemiological Profile of Paediatric-Onset Multiple Sclerosis in Poland. J. Clin. Med., 11.","DOI":"10.3390\/jcm11247494"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/B978-0-12-801914-6.00006-4","article-title":"Pediatric-Onset Multiple Sclerosis as a Window Into Early Disease Targets and Mechanisms","volume":"Volume 1","author":"Fadda","year":"2016","journal-title":"Translational Neuroimmunology in Multiple Sclerosis: From Disease Mechanisms to Clinical Applications"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa067597","article-title":"Natural history of multiple sclerosis with childhood onset","volume":"356","author":"Renoux","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: From pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: Time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1177\/1352458519881994","article-title":"Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype","volume":"26","author":"Zhou","year":"2020","journal-title":"Mult. Scler. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7224\/1537-2073.2015-097","article-title":"CME\/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal","volume":"18","author":"Charlson","year":"2016","journal-title":"Int. J. MS Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102816","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical Features of Late-Onset Multiple Sclerosis: A Systematic Review and Meta-analysis","volume":"50","author":"Naseri","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mirmosayyeb, O., Brand, S., Barzegar, M., Afshari-Safavi, A., Nehzat, N., Shaygannejad, V., and Bahmani, D.S. (2020). Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051326"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0883073819845827","article-title":"Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature","volume":"34","author":"Jeong","year":"2019","journal-title":"J. Child Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102260","DOI":"10.1016\/j.msard.2020.102260","article-title":"Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis","volume":"44","author":"Yan","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/1352458514551453","article-title":"Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice","volume":"21","author":"Ahn","year":"2015","journal-title":"Mult. Scler. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17590914221118502","DOI":"10.1177\/17590914221118502","article-title":"Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination","volume":"14","author":"Correale","year":"2022","journal-title":"ASN Neuro"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-320587","article-title":"Impact of natural menopause on multiple sclerosis: A multicentre study","volume":"90","author":"Baroncini","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1352458517737396","article-title":"Hormones and MS: Risk factors, biomarkers, and therapeutic targets","volume":"24","author":"Bove","year":"2018","journal-title":"Mult. Scler. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"105469","DOI":"10.1016\/j.msard.2024.105469","article-title":"Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study","volume":"84","author":"Beckmann","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.msard.2014.02.004","article-title":"Late onset multiple sclerosis: Is it really late onset?","volume":"3","author":"Roohani","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00415-008-0778-x","article-title":"Clinical characteristics of patients with late-onset multiple sclerosis","volume":"255","author":"Kis","year":"2008","journal-title":"J. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neurad.2023.08.002","article-title":"Radiological features of late-onset multiple sclerosis: A systematic review and meta-analysis","volume":"50","author":"Nasiri","year":"2023","journal-title":"J. Neuroradiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.5603\/PJNNS.a2020.0069","article-title":"Pediatric multiple sclerosis\u2014Current status of epidemiology, diagnosis and treatment","volume":"54","author":"Brola","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0883073817739789","article-title":"Pediatric-Onset Multiple Sclerosis: A Single Center Study","volume":"33","author":"Yamamoto","year":"2017","journal-title":"J. Child Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4-2","DOI":"10.1212\/WNL.92.15_supplement.P4.2-075","article-title":"Late Onset Multiple Sclerosis: Clinical and Radiographic Characteristics (P4. 2-075)","volume":"92","author":"Thakolwiboon","year":"2019","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/dmcn.14212","article-title":"Paediatric multiple sclerosis: A new era in diagnosis and treatment","volume":"61","author":"Duignan","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105132","DOI":"10.1016\/j.msard.2023.105132","article-title":"Clinical and radiologic differences between early onset, late onset, and very late onset adult multiple sclerosis","volume":"80","author":"Palathinkara","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.26843","article-title":"Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple Sclerosis","volume":"95","author":"Knowles","year":"2024","journal-title":"Ann. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.20344\/amp.12486","article-title":"Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the First Year After Diagnosis","volume":"34","author":"Pinto","year":"2021","journal-title":"Acta Med. Port."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.msard.2013.06.004","article-title":"Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years","volume":"3","author":"Benson","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00247-019-04582-3","article-title":"Pediatric multiple sclerosis: From clinical basis to imaging spectrum and differential diagnosis","volume":"50","author":"Padilha","year":"2020","journal-title":"Pediatr. Radiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1844","DOI":"10.1212\/WNL.0000000000010414","article-title":"Pediatric Multiple Sclerosis Severity Score in a large US cohort","volume":"95","author":"Santoro","year":"2020","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jamaneurol.2021.1008","article-title":"Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis","volume":"78","author":"Baroncini","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"E2764","DOI":"10.1212\/WNL.0000000000007647","article-title":"Long-term disability progression of pediatric-onset multiple sclerosis","volume":"92","author":"McKay","year":"2019","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"102588","DOI":"10.1016\/j.msard.2020.102588","article-title":"Late onset multiple sclerosis is associated with more severe ventricle expansion","volume":"46","author":"Jakimovski","year":"2020","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/1\/107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:27:39Z","timestamp":1759919259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/1\/107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["medicina61010107"],"URL":"https:\/\/doi.org\/10.3390\/medicina61010107","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}